High Gal-1 tissue levels have been reported in pancreatic cancer in human [20, 22, 36] and mouse [23, 24]; however, its expression in CP and during different steps of PDA progression have not been thoroughly investigated. The gene discussed is CP; the disease is Patent ductus arteriosus.